全文获取类型
收费全文 | 1211599篇 |
免费 | 87478篇 |
国内免费 | 3004篇 |
专业分类
耳鼻咽喉 | 15819篇 |
儿科学 | 41016篇 |
妇产科学 | 33090篇 |
基础医学 | 175791篇 |
口腔科学 | 32789篇 |
临床医学 | 107400篇 |
内科学 | 240743篇 |
皮肤病学 | 28618篇 |
神经病学 | 98530篇 |
特种医学 | 44890篇 |
外国民族医学 | 385篇 |
外科学 | 176743篇 |
综合类 | 24820篇 |
一般理论 | 449篇 |
预防医学 | 98024篇 |
眼科学 | 26817篇 |
药学 | 86998篇 |
3篇 | |
中国医学 | 2704篇 |
肿瘤学 | 66452篇 |
出版年
2021年 | 10469篇 |
2019年 | 11261篇 |
2018年 | 17589篇 |
2017年 | 12801篇 |
2016年 | 13959篇 |
2015年 | 15702篇 |
2014年 | 20044篇 |
2013年 | 30878篇 |
2012年 | 44102篇 |
2011年 | 46145篇 |
2010年 | 26209篇 |
2009年 | 23346篇 |
2008年 | 42004篇 |
2007年 | 44567篇 |
2006年 | 43950篇 |
2005年 | 42503篇 |
2004年 | 40951篇 |
2003年 | 38873篇 |
2002年 | 37211篇 |
2001年 | 52017篇 |
2000年 | 53330篇 |
1999年 | 44932篇 |
1998年 | 12079篇 |
1997年 | 10813篇 |
1996年 | 10812篇 |
1995年 | 10386篇 |
1994年 | 9646篇 |
1993年 | 8954篇 |
1992年 | 34823篇 |
1991年 | 33753篇 |
1990年 | 33234篇 |
1989年 | 31863篇 |
1988年 | 29075篇 |
1987年 | 29126篇 |
1986年 | 27149篇 |
1985年 | 26146篇 |
1984年 | 19502篇 |
1983年 | 16409篇 |
1982年 | 9813篇 |
1979年 | 17842篇 |
1978年 | 12910篇 |
1977年 | 10955篇 |
1976年 | 10277篇 |
1975年 | 10822篇 |
1974年 | 13155篇 |
1973年 | 12685篇 |
1972年 | 11683篇 |
1971年 | 10898篇 |
1970年 | 10127篇 |
1969年 | 9521篇 |
排序方式: 共有10000条查询结果,搜索用时 16 毫秒
991.
A. Perez S. E. Clements E. Benton A. Robson B. Bhogal C. M. Stefanato D. McGibbon 《Clinical and experimental dermatology》2009,34(8):e931-e933
We report a case of localized bullous pemphigoid (BP) in a woman patient with primary lymphoedema tarda. There is only one previous case reported of localized pemphigoid in an area of lymphoedema, this being of the cicatricial variant. Slow circulation in the lymphatic vessels, increased capillary permeability with preferential localization of antibodies in the area, and potential cleavage of the epidermal junction due to increased hydrostatic pressure leading to autoimmunity, have all been advocated as possible pathogenic mechanisms. Nevertheless, we consider that the mechanism by which localized pemphigoid arises on lymphoedema remains elusive, based on a previous case of generalized BP sparing an area of postsurgical lymphoedema. 相似文献
992.
J.P. Thyssen P. Jensen B.C. Carlsen K. Engkilde T. Menné J.D. Johansen 《The British journal of dermatology》2009,161(6):1288-1293
Background Chromium allergy has traditionally been caused by occupational skin contact with cement. In 1983, Danish legislation made the addition of ferrous sulphate compulsory in cement to reduce the water‐soluble chromium content to not more than 2 ppm. An effect from this intervention has previously been demonstrated among Danish construction workers. Objectives To investigate the development of chromium allergy among patients with dermatitis tested between 1985 and 2007 in Denmark. Furthermore, to determine causative exposures in patients with chromium allergy. Patients and methods A retrospective analysis of patch test data was performed (n = 16 228) and charts from patients with chromium allergy were reviewed. Comparisons were made using a χ2 test. Logistic regression analyses were used to test for associations. Results The prevalence of chromium allergy decreased significantly from 3·6% in 1985 to 1% in 1995 (Ptrend < 0·001) but increased to 3·3% in 2007 (Ptrend < 0·001). The frequency of clinically relevant cement exposure decreased significantly among patients with chromium allergy from 12·7% in 1989–1994 to 3·0% (P < 0·01) in 1995–2007, whereas the frequency of relevant leather exposure increased significantly from 24·1% during 1989–1994 to 45·5% during 1995–2007 (P < 0·02). Conclusions Chromium allergy is currently increasing in Denmark due to leather exposure. 相似文献
993.
Andreas Lange Claudia Kistler Tanja B. Jutzi Alexandr V. Bazhin Claus Detlev Klemke Dirk Schadendorf Stefan B. Eichmüller 《Experimental dermatology》2009,18(6):527-535
Abstract: The identification of tumor-specific proteins located at the plasma membrane is hampered by numerous methodological pitfalls many of which are associated with the post-translational modification of such proteins. Here, we present a new combination of detergent fractionation of cells and of subtractive suppression hybridization (SSH) to gain overexpressed genes coding for membrane-associated or secreted proteins. Fractionation of subcellular components by digitonin allowed sequestering mRNA of the rough Endoplasmatic reticulum and thereby increasing the percentage of sequences coding for membrane-bound proteins. Fractionated mRNAs from the cutaneous T-cell lymphoma (CTCL) cell line HuT78 and from normal peripheral blood monocytes were used for SSH leading to the enrichment of sequences overexpressed in the tumor cells. We identified some 21 overexpressed genes, among them are GPR137B, FAM62A, NOMO1, HSP90, SLIT1, IBP2, CLIF, IRAK and ARC. mRNA expression was tested for selected genes in CTCL cell lines, skin specimens and peripheral blood samples from CTCL patients and healthy donors. Several of the detected sequences are clearly related to cancer, but have not yet been associated with CTCL. qPCR confirmed an enrichment of these mRNAs in the rough endoplasmic reticulum fraction. RT-PCR confirmed the expression of these genes in skin specimens and peripheral blood of CTCL patients. Western blotting verified protein expression of HSP90 and IBP2 in HuT78. GPR137B could be detected by immunohistology in HuT78 and in keratinocytes of dysplastic epidermis, but also in sweat glands of healthy skin. In summary, we developed a new technique, which allows identifying overexpressed genes coding preferentially for membrane-associated proteins. 相似文献
994.
995.
Psoriasis is a chronic inflammatory condition that often requires life-long treatment. Conventional therapies have not fully met the needs of psoriatic patients, because of limited efficacy, adverse effects with cumulative use, and patient inconvenience. In the past decade, biologic immunotherapies have become accepted treatments for psoriasis as a result of perceived efficacy and safety on the part of patients and practitioners. However, most data on these medications come from relatively limited short-term trials. In this review, we will focus on the available long-term data on the efficacy of the biologic agents. We will emphasize the strengths and weakness of the available data of the biologic agents that are Food and Drug Administration (FDA)-approved for the treatment of moderate to severe psoriasis (alefacept, efalizumab, * etanercept, infliximab, and adalimumab), with the inclusion of a newer agent currently under FDA evaluation (ustekinumab). 相似文献
996.
Beta2-Microglobulin 总被引:1,自引:0,他引:1
Among the uremic toxins in the "middle molecule" range, beta2-microglobulin (β2-M) is certainly one of the most frequently studied compounds. Its serum level increases with the progression of chronic kidney disease, to reach very high concentrations in patients with end-stage kidney disease. It is the major protein component of dialysis-related amyloidosis, a dramatic complication which results from high extracellular concentration and posttranslational modification of β2-M and a number of other promoters of amyloid fibril formation and deposition in osteo-articular tissues. Effective removal of β2-M can be achieved with highly effective hemodialysis and hemodiafiltration techniques but predialysis session serum levels cannot be normalized. The prevalence and severity of β2-M amyloidosis appear to have decreased in the last 20 years, although its occurrence may simply be delayed. 相似文献
997.
998.
999.
1000.